+499.5%
MRNA vs EME
+19.7%
+479.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +1.7% | -4.0% | -2.1% |
| 7D | +5.5% | +1.9% | +3.6% | +5.6% |
| 30D | +158.7% | -8.3% | +167.0% | +157.9% |
| 3M | +182.1% | -10.7% | +192.9% | +176.7% |
| 6M | +151.8% | +1.9% | +149.9% | +144.5% |
| YTD | +393.6% | +23.5% | +370.1% | +385.6% |
| 1Y | +499.5% | +18.0% | +481.5% | +407.6% |
| All | +499.5% | +19.7% | +479.8% | +407.6% |
Cumulative growth
Daily Returns
Daily percentage return beside EME.
Daily Out/Under-Performance
Portfolio return minus EME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling